Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for prevention of peri-operative myocardial injury in major orthopaedic surgery
ACTRN12616001634460Phase 2Not yet recruiting
- Sponsor
- Northern Health
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Myocardial injury comparing Ivabradine + standard of care with Standard of care (2 arms). Primary endpoint: Peri-operative myocardial injury. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
ivabradine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on ACTRN12616001634460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001634460.